ES2130083A1 - Procedimiento para la obtencion de los enantiomeros de cizolirtina. - Google Patents

Procedimiento para la obtencion de los enantiomeros de cizolirtina.

Info

Publication number
ES2130083A1
ES2130083A1 ES09701728A ES9701728A ES2130083A1 ES 2130083 A1 ES2130083 A1 ES 2130083A1 ES 09701728 A ES09701728 A ES 09701728A ES 9701728 A ES9701728 A ES 9701728A ES 2130083 A1 ES2130083 A1 ES 2130083A1
Authority
ES
Spain
Prior art keywords
olirtine
cis
enantiomer
order
obtaining enantiomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09701728A
Other languages
English (en)
Other versions
ES2130083B1 (es
Inventor
Antoni Torrens-Jover
Jordi Firgola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009701728A priority Critical patent/ES2130083B1/es
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to PCT/ES1998/000223 priority patent/WO1999007684A1/es
Priority to AU84426/98A priority patent/AU8442698A/en
Priority to DE69809282T priority patent/DE69809282T2/de
Priority to CA002299447A priority patent/CA2299447C/en
Priority to JP2000506188A priority patent/JP2001512718A/ja
Priority to ES98935042T priority patent/ES2187044T3/es
Priority to PT98935042T priority patent/PT1029852E/pt
Priority to EP98935042A priority patent/EP1029852B1/en
Priority to US09/485,023 priority patent/US6118009A/en
Priority to AT98935042T priority patent/ATE227272T1/de
Priority to DK98935042T priority patent/DK1029852T3/da
Publication of ES2130083A1 publication Critical patent/ES2130083A1/es
Application granted granted Critical
Publication of ES2130083B1 publication Critical patent/ES2130083B1/es
Priority to NO20000560A priority patent/NO314499B1/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento papa la obtención de los enantiómeros de cizolirtina. El procedimiento comprende (a) la reducción de enantioselectiva de una cetona proquiral (III) mediante en empleo de un reductor y un catalizador quiral derivados de boro en un disolvente o mezcla de disolventes anhidros para formar un enantiómero de un alcohol (II), y (b) la alquilación de (II), en condiciones de transferencia de fase, opcionalmente previo aislamiento y purificación del mismo, con 2-cloro-N, N-dimetiletilamina, para formar un enantiómero de (I). La cizolirtina tiene propiedades analgésicas. Fórmulas (I), (II) y (III).
ES009701728A 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina. Expired - Fee Related ES2130083B1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ES009701728A ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.
AT98935042T ATE227272T1 (de) 1997-08-04 1998-07-31 Verfahren zur gewinnung von enantiomeren von cis- olirtin
DE69809282T DE69809282T2 (de) 1997-08-04 1998-07-31 Verfahren zur gewinnung von enantiomeren von cis-olirtin
CA002299447A CA2299447C (en) 1997-08-04 1998-07-31 Procedure for obtaining the enantiomers of cyzolirtine
JP2000506188A JP2001512718A (ja) 1997-08-04 1998-07-31 シゾリルチンの鏡像体を得るための方法
ES98935042T ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.
PCT/ES1998/000223 WO1999007684A1 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de los enantiomeros de cizolirtina
EP98935042A EP1029852B1 (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
US09/485,023 US6118009A (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
AU84426/98A AU8442698A (en) 1997-08-04 1998-07-31 Process for obtaining enantiomers of cis-olirtine
DK98935042T DK1029852T3 (da) 1997-08-04 1998-07-31 Fremgangsmåde til udvinding af enantiomerer af cis-olirtin
PT98935042T PT1029852E (pt) 1997-08-04 1998-07-31 Processo para obtencao de enantiomeros de cis-olirtina
NO20000560A NO314499B1 (no) 1997-08-04 2000-02-03 Fremgangsmåte for å oppnå enantiomerer av cis-olirtin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701728A ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.

Publications (2)

Publication Number Publication Date
ES2130083A1 true ES2130083A1 (es) 1999-06-16
ES2130083B1 ES2130083B1 (es) 2000-01-16

Family

ID=8300306

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009701728A Expired - Fee Related ES2130083B1 (es) 1997-08-04 1997-08-04 Procedimiento para la obtencion de los enantiomeros de cizolirtina.
ES98935042T Expired - Lifetime ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES98935042T Expired - Lifetime ES2187044T3 (es) 1997-08-04 1998-07-31 Procedimiento para la obtencion de enantiomeros de cizolirtina.

Country Status (12)

Country Link
US (1) US6118009A (es)
EP (1) EP1029852B1 (es)
JP (1) JP2001512718A (es)
AT (1) ATE227272T1 (es)
AU (1) AU8442698A (es)
CA (1) CA2299447C (es)
DE (1) DE69809282T2 (es)
DK (1) DK1029852T3 (es)
ES (2) ES2130083B1 (es)
NO (1) NO314499B1 (es)
PT (1) PT1029852E (es)
WO (1) WO1999007684A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
JP2007531785A (ja) * 2004-04-05 2007-11-08 ラボラトリオス・デル・デエレ・エステベ・エセ・ア 活性物質組合せ物
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1838678A1 (en) * 2004-12-17 2007-10-03 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
EP1671953A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining cizolirtine and its enantiomers
EP1671968A1 (en) * 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
WO2010123999A2 (en) * 2009-04-21 2010-10-28 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
DE102010056283A1 (de) 2010-12-24 2012-06-28 Volkswagen Ag Wärmeübertragungssystem
CN108558695A (zh) * 2018-05-15 2018-09-21 浙江华贝药业有限责任公司 2，2，2-三氟-n-[(1s，4s)-4-羟基四氢萘-1-基]-乙酰胺制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305180A2 (en) * 1987-08-27 1989-03-01 The President And Fellows Of Harvard College Enantioselective reduction of ketones
WO1993023408A1 (en) * 1992-05-14 1993-11-25 Pfizer Inc. Enantioselective oxazaborolidine catalysts
WO1995029146A1 (en) * 1994-04-22 1995-11-02 Sepracor, Inc. Asymmetric synthesis of (r)- and (s)-arylethanolamines from iminoketones

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305180A2 (en) * 1987-08-27 1989-03-01 The President And Fellows Of Harvard College Enantioselective reduction of ketones
WO1993023408A1 (en) * 1992-05-14 1993-11-25 Pfizer Inc. Enantioselective oxazaborolidine catalysts
WO1995029146A1 (en) * 1994-04-22 1995-11-02 Sepracor, Inc. Asymmetric synthesis of (r)- and (s)-arylethanolamines from iminoketones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bioorganic & Medicinal Chemistry Letters, Vol. 3, no 2, paginas 269-272, 1993. J.A. HUESO-RODRIGUEZ et al., "Preparation of the enantiomers of the analgesic E-3710". Citada en la solicitud. *

Also Published As

Publication number Publication date
NO314499B1 (no) 2003-03-31
DE69809282T2 (de) 2003-09-11
CA2299447A1 (en) 1999-02-18
WO1999007684A1 (es) 1999-02-18
AU8442698A (en) 1999-03-01
PT1029852E (pt) 2003-03-31
ES2130083B1 (es) 2000-01-16
EP1029852B1 (en) 2002-11-06
DK1029852T3 (da) 2003-02-24
ATE227272T1 (de) 2002-11-15
CA2299447C (en) 2007-05-29
DE69809282D1 (de) 2002-12-12
EP1029852A1 (en) 2000-08-23
JP2001512718A (ja) 2001-08-28
US6118009A (en) 2000-09-12
NO20000560D0 (no) 2000-02-03
NO20000560L (no) 2000-03-29
ES2187044T3 (es) 2003-05-16

Similar Documents

Publication Publication Date Title
ES2130083A1 (es) Procedimiento para la obtencion de los enantiomeros de cizolirtina.
Vrubliauskas et al. Cobalt‐catalyzed hydrogen‐atom transfer induces bicyclizations that tolerate electron‐rich and electron‐deficient intermediate alkenes
Yin et al. Enantioselective Synthesis of N− N Biaryl Atropisomers through Iridium (I)‐Catalyzed C− H Alkylation with Acrylates
EP1019414A4 (en) METHOD FOR PRODUCING ORGANIC BORONIC ACID DERIVATIVES WITH THE AID OF DIBORONIC ACID
PL392725A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
Quallich et al. Diphenyloxazaborolidine a new catalyst for enantioselective reduction of ketones
Garlets et al. Asymmetric Palladium‐Catalyzed Alkene Carboamination Reactions for the Synthesis of Cyclic Sulfamides
ATE209620T1 (de) Verfahren zur herstellung von nitrobiphenylen
Ishitani et al. Enantioselective sequential‐flow synthesis of baclofen precursor via asymmetric 1, 4‐Addition and chemoselective hydrogenation on platinum/carbon/calcium phosphate composites
KR960702468A (ko) 거울상선택적 옥사자보로리딘 촉매(Enantioselective oxazaborolidine catalysts)
Wang et al. Destruction and construction: application of dearomatization strategy in aromatic carbon–nitrogen bond functionalization
Motaleb et al. Phosphite‐Catalyzed C− H Allylation of Azaarenes via an Enantioselective [2, 3]‐Aza‐Wittig Rearrangement
Liu et al. Copper-catalysed enantioselective intramolecular etherification of propargylic esters: synthetic approach to chiral isochromans
Gotoh et al. One-pot synthesis of chiral bicyclo [3.3. 0] octatrienes using diphenylprolinol silyl ether-mediated ene-type reaction
Lu et al. Access to Polycyclic Indol (en) ines via Base‐Catalyzed Intramolecular Dearomatizing 3‐Alkenylation of Alkynyl Indoles
Cheng et al. Stereoselective Transformations of α‐Trifluoromethylated Ketoximes to Optically Active Amines by Enzyme–Nanometal Cocatalysis: Synthesis of (S)‐Inhibitor of Phenylethanolamine N‐Methyltransferase
Yoon et al. Reduction of azides to amines with borohydride exchange resin–nickel acetate
Rulev et al. Direct Access to Cumbersome Aminated Quaternary Centers by Hyperbaric Aza‐Michael Additions
Kim et al. Concise Asymmetric Total Synthesis of ent‐Ancistrocladinium A
Chandrasekhar et al. Inexpensive protocol for reduction of imines to amines using polymethylhydrosiloxane (PMHS)
AU3345599A (en) A process for preparing chiral (s)-2,3-disubstituted-1-propylamine derivatives
CN108752170A (zh) 一种催化苄醇类化合物醚化的方法
Yang et al. Efficient Construction of Atropisomeric Arylamines through a Diastereoselective Buchwald‐Hartwig Amination
Oyamada et al. Enantioselective Allenylation of Ketimines Derived from Isatins Using Chiral Bis (imidazoline)‐Palladium Catalysts
ES485645A1 (es) Un procedimiento mejorado para preparar n-fenil-n'-alcohil- fenilendiamina

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990616

Kind code of ref document: A1

Effective date: 19990616

FD2A Announcement of lapse in spain

Effective date: 20180807